- Home
- APLT vs GRWG Comparison
APLT vs GRWG Comparison
Compare APLT & GRWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- GRWG
- Stock Information
- Founded
- APLT 2016
- GRWG 2008
- Country
- APLT United States
- GRWG United States
- Employees
- APLT N/A
- GRWG N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- GRWG RETAIL: Building Materials
- Sector
- APLT Health Care
- GRWG Consumer Discretionary
- Exchange
- APLT Nasdaq
- GRWG Nasdaq
- Market Cap
- APLT 80.3M
- GRWG 82.3M
- IPO Year
- APLT 2019
- GRWG N/A
- Fundamental
- Price
- APLT $0.52
- GRWG $1.11
- Analyst Decision
- APLT Buy
- GRWG Buy
- Analyst Count
- APLT 7
- GRWG 4
- Target Price
- APLT $6.10
- GRWG $2.75
- AVG Volume (30 Days)
- APLT 1.6M
- GRWG 770.5K
- Earning Date
- APLT 05-08-2025
- GRWG 03-13-2025
- Dividend Yield
- APLT N/A
- GRWG N/A
- EPS Growth
- APLT N/A
- GRWG N/A
- EPS
- APLT N/A
- GRWG N/A
- Revenue
- APLT N/A
- GRWG $188,866,000.00
- Revenue This Year
- APLT N/A
- GRWG $0.59
- Revenue Next Year
- APLT $2,426.33
- GRWG N/A
- P/E Ratio
- APLT N/A
- GRWG N/A
- Revenue Growth
- APLT N/A
- GRWG N/A
- 52 Week Low
- APLT $0.43
- GRWG $0.91
- 52 Week High
- APLT $10.62
- GRWG $3.38
- Technical
- Relative Strength Index (RSI)
- APLT 43.47
- GRWG 42.14
- Support Level
- APLT $0.52
- GRWG $1.11
- Resistance Level
- APLT $0.62
- GRWG $1.30
- Average True Range (ATR)
- APLT 0.05
- GRWG 0.10
- MACD
- APLT 0.01
- GRWG 0.02
- Stochastic Oscillator
- APLT 23.19
- GRWG 51.28
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, advanced indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.